WHO ICTRP trial
Dysosmia and Dysgeusia in COVID-19 patients
DRKS00021516 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00021516 |
|---|---|
| Public title | Dysosmia and Dysgeusia in COVID-19 patients |
| Scientific title | Dysosmia and Dysgeusia in COVID-19 patients |
| Primary sponsor | Kantonsspital Aarau |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Switzerland |
| Conditions | U07.1;COVID-19, virus identified;U07.1 |
| Interventions | Group 1: 100 patients: questionnaires, 50 patients questionnaires and smell and taste test |
| Registration date | Apr 22, 2020 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: